IP Library Granted Patent US 8,280,126
Granted Patent B2
US 8,280,126 · App. 12/083,800 · Granted Oct 2, 2012

Cartilage curvature

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,280,126
App. No.
12/083,800
Granted
Oct 2, 2012
Kind
B2
Abstract

A method for the analysis of three dimensional scan data representing an articular cartilage is provided to extract a quantitative parameter indicative of joint pathology. A measure of local curvature of the cartilage is determined within a region of interest. The value of the quantitative parameter of this joint derived from this measure is compared with the value of a similar quantitative parameter previously established in respect of healthy joints and/or joints characterized by a pathology.

Claims (59)

1. A method for the analysis of three dimensional scan data representing an articular cartilage to extract a quantitative parameter indicative of joint pathology, which method comprises determining a measure of the local curvature of the cartilage within a region of interest, and further comprising comparing the measured value of said quantitative parameter for the joint with values of the quantitative parameter previously established in respect of joints characterized by a pathology.

2. The method as claimed in claim 1 , wherein the method comprises determining a measure of the 3D local curvature at a scale arranged to result in a measure of curvature above 40 m −1 .

3. The method as claimed in claim 2 , wherein said scale is arranged to result in a measure of curvature between 40 m −1 and 200 m −1 .

4. The A method as claimed in claim 1 , wherein said region of interest lies in a load bearing area of said cartilage.

5. The method as claimed in claim 1 , wherein the region of interest is selected to lie in an interior region of a cartilage sheet separated from the edges of said sheet.

6. The method as claimed in claim 1 , wherein said cartilage is a knee cartilage.

7. The method as claimed in claim 4 , wherein said knee cartilage is a tibial cartilage.

8. The method as claimed in claim 5 , wherein said tibial cartilage is a medial tibial cartilage.

9. The method as claimed in claim 1 , wherein a comparison of said quantitative parameter is made both with values of the quantitative parameter previously established in respect of healthy joints and with values of said quantitative parameter previously established in respect of joints characterized by a pathology.

10. The method as claimed in claim 6 , wherein said pathology is osteoarthritis, rheumatoid arthritis, villonodular synovitis, Lipoid dematoarthritis (Multicentric reticulohistiocytosis), Enteropathic arthritis, hemophilia (intraarticular bleeding), Gout, Familial Mediterranean fever, Pseudogout, Ochronotic arthropathy, Secondary osteoarthritis, Syphilis (tabes dorsalis), Pyrogenic arthritis, Tuberculous arthritis or Fungal arthritis.

11. The method as claimed in claim 1 , wherein said three dimensional scan data is produced by magnetic resonance imaging (MRI).

12. The method as claimed in claim 8 , wherein said quantitative parameter is derived from changes between adjacent locations within the region of interest in directions defined with respect to normals to a selected cartilage surface or interior contour.

13. The method as claimed in claim 12 , wherein the changes in the directions of normals are weighted by the inverse distance to the local centre point.

14. The method as claimed in claim 1 , wherein said quantitative parameter represents an average of said changes in direction over said region of interest.

15. The method as claimed in claim 12 , wherein said quantitative parameter is quantitatively related to the average value over the region of interest of ‘curvature (p)’ given for each point p in the region of interest by the expression:

curvature

(

p

)

=

1

N

n

N

a

cos

(

normal

(

p

)

·

normal

(

n

)

)

reflecting the mean angle between the surface normal at surface point p with a neighborhood set N and the normals at the neighboring surface points n.

16. The method as claimed in claim 12 , wherein points p are sampled at a spacing of from 0.2 to 2 mm in evaluating said average value of curvature(p).

17. The method as claimed in claim 15 , wherein said neighborhood set N of neighboring points for any point P occupies an area of from 1 mm 2 to 4 mm 2 .

18. The method as claimed in claim 9 , wherein said quantitative parameter is derived from changes in mean curvature flow over the region of interest taken from the maximal and minimal curvature associated with corresponding directions.

19. The method as claimed in claim 15 , wherein said mean curvature flow is calculated by iteratively calculating the average of the absolute value of mean curvature at an articular surface.

20. The method as claimed in claim 1 , wherein said region of interest is from 1 cm 2 to 8 cm 2 in area.

21. The method as claimed in claim 1 , further comprising combining said measure of local curvature with one or more of (a) a measure of cartilage volume, (b) a measure of cartilage thickness, and (c) a measure of cartilage smoothness, to provide an improved discrimination between said combined measure when representing joint pathology and equivalent measures derived from healthy joints.

22. The method as claimed in claim 1 , further comprising analyzing said scan data to perform an automatic segmentation of image data representing cartilage from bone and other background prior to extracting said quantitative parameter.

23. The method as claimed in claim 1 , wherein a value for said quantitative parameter which is higher than that established for healthy joints is taken as indicative of probable joint pathology.

24. The method as claimed in claim 1 , further comprising normalizing the position of the knee prior to segmentation.

Assignments (24)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY RECORDED AT REEL 069939 AND FRAME 0472 Recorded Mar 24, 2026
From: ALTER DOMUS (US) LLC
To: ERESEARCHTECHNOLOGY, INC.; BIOCLINICA, INC.
Reel/Frame 075224/0052 →
RELEASE OF SECURITY INTEREST AT REEL/FRAME 063141/0589 Recorded Jan 17, 2025
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: BIOCLINICA, INC.
Reel/Frame 069939/0414 →
RELEASE OF SECURITY INTEREST AT REEL/FRAME 063123/0066 Recorded Jan 17, 2025
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: BIOCLINICA, INC.
Reel/Frame 069939/0325 →
SECURITY AGREEMENT Recorded Jan 17, 2025
From: BIOCLINICA, INC.; ERESEARCHTECHNOLOGY, INC.
To: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
Reel/Frame 069939/0472 →
SECOND LIEN SECURITY AGREEMENT Recorded Mar 22, 2023
From: BIOCLINICA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 063141/0589 →
FIRST LIEN SECURITY AGREEMENT Recorded Mar 21, 2023
From: BIOCLINICA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 063123/0066 →
FIRST LIEN RELEASE OF SECURITY INTEREST IN PATENTS Recorded Apr 27, 2021
From: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
To: BIOCLINICA, INC.
Reel/Frame 056064/0341 →
SECOND LIEN RELEASE OF SECURITY INTEREST IN PATENTS Recorded Apr 27, 2021
From: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
To: BIOCLINICA, INC.
Reel/Frame 056064/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2019
From: SYNARC INC.
To: BIOCLINICA, INC.
Reel/Frame 048468/0743 →
PATENT SECURITY AGREEMENT Recorded Oct 21, 2016
From: BIOCLINICA, INC.; SYNARC INC.
To: JEFFERIES FINANCE LLC
Reel/Frame 040458/0810 →
RELEASE OF SECOND LIEN SECURITY Recorded Oct 21, 2016
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BIOCLINICA, INC.; SYNARC, INC.
Reel/Frame 040458/0849 →
RELEASE OF FIRST LIEN SECURITY Recorded Oct 21, 2016
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BIOCLINICA, INC.; SYNARC, INC.
Reel/Frame 040458/0915 →
FIRST LIEN SECURITY AGREEMENT Recorded Oct 21, 2016
From: BIOCLINICA, INC.; SYNARC INC.
To: JEFFERIES FINANCE LLC
Reel/Frame 040458/0800 →
RELEASE OF SECURITY INTEREST Recorded Oct 21, 2016
From: BANK OF NEW YORK MELLON
To: BIOCLINICA, INC.; SYNARC INC.
Reel/Frame 040085/0965 →
SECURITY INTEREST Recorded Sep 18, 2015
From: BIOCLINICA, INC.; SYNARC INC.
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 036596/0889 →
PATENT SECURITY AGREEMENT (SECOND LIEN) Recorded Apr 28, 2014
From: SYNARC INC.
To: CREDIT SUISSE AG, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 032777/0066 →
PATENT SECURITY AGREEMENT (FIRST LIEN) Recorded Apr 28, 2014
From: SYNARC INC.
To: CREDIT SUISSE AG, AS FIRST LIEN COLLATERAL AGENT
Reel/Frame 032776/0798 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN UNITED STATES PATENTS (RELEASES REEL 030157 FRAME 0547) Recorded Apr 28, 2014
From: BANK OF AMERICA, N.A.
To: SYNARC INC.
Reel/Frame 032776/0402 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN U.S. PATENTS (REEL 027282, FRAME 0959) Recorded Apr 8, 2013
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: SYNARC INC.
Reel/Frame 030173/0902 →
NOTICE OF SECURITY INTEREST IN PATENTS Recorded Apr 5, 2013
From: SYNARC INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 030157/0547 →
SECURITY AGREEMENT Recorded Nov 28, 2011
From: SYNARC INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 027282/0959 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2011
From: NORDIC BIOSCIENCE IMAGING A/S, A.K.A. SYNARC IMAGING TECHNOLOGIES A/S
To: SYNARC INC.
Reel/Frame 026693/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2009
From: DAM, ERIK B.; FOLKESSON, JENNY; PETTERSON, PAOLA; OLSEN, OLE F.; NIELSEN, MADS; CHRISTIANSEN, CLAUS
To: NORDIC BIOSCIENCE A/S
Reel/Frame 022382/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2009
From: NORDIC BIOSCIENCE A/S
To: NORDIC BIOSCIENCE IMAGING A/S
Reel/Frame 022299/0325 →